About Medplus Health Services Limited
Data last updated: 14 July 2026
Medplus Health Services Limited is a public limited company based in Hyderabad, Telangana, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 30 November 2006, the company has been in operation for over 20 years.
Registered with ROC Hyderabad under CIN L85110TG2006PLC051845. Listed on BSE: 543427.
Capital: an authorised share capital of ₹61.19 Cr and a paid-up capital of ₹24.03 Cr. Formerly known as Medplus Health Services Private Limited. It is led by directors including Madhukar Reddy Gangadi and Muralidharan Thyagarajan.
Last AGM: 15 September 2025. Financial statements filed for year ended 31 March 2025. Office: Hyderabad, Telangana.
As per NSE-filed consolidated financials for FY 2026, the company reported a revenue of ₹6,892.47 Cr, a growth of 12.33% compared to the previous year. The net worth stands at ₹1,974.65 Cr (up 13.49% YoY). Total assets are valued at ₹3,932.53 Cr (up 17.04% YoY).
The company has a workforce of approximately 1,343 employees as per the latest available data. Its group structure includes 12 subsidiaries.
The company is associated with 4 brands - Medpluslens, Medplus, Karbon, Medplusmart. As per MCA filings, the company has open charges of ₹11 Cr and satisfied charges of ₹218.05 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medplusindia.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Apps
-
Registered AddressH. No: 11 – 6 – 56 Survey No: 257 & 258/1 Opp: Idpl Railway Siding Road Moosapet, Kukatpally, Hyderabad, Telangana, India – 500037
-
IndustryPharma, Pharmaceutical Retailers & Distributors
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Medplus Health Services Limited
Medplus Health Services Limited has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L85110TG2006PLC051845, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85110TG2006PLC051845 | Current |
| U85110TG2006PTC051845 | Previous |
| U85110TG2006PLC051845 | Previous |
| U85110AP2006PTC051845 | Previous |
Associated Brands with Medplus Health Services Limited
Medplus Health Services Limited operates multiple associated brands including MedPlusLens, MedPlus, and Karbon. These brands represent Medplus Health Services Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Online platform selling eyewear products like frames and lenses to consumers. | medpluslens.com | |
| Medicines and health products are retailed through pharmacy outlets. | medplusindia.com | |
| International payment and corporate expense solutions are offered to businesses. | karboncard.com | |
| General and prescription medicines are ordered via web/mobile platform. | medplusmart.com |
Competitors & Alternatives of Medplus Health Services Limited
Brands and companies operating in the same space as Medplus Health Services Limited include Tata 1mg, Zaggle, SastaSundar and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Tata 1mg
|
Provider of an online pharmacy with doctor listing and teleconsultation services | Delhi, India, India | 2015 |
Zaggle
|
Business spends, payments, and rewards are streamlined by automated workflows. | Hyderabad, India, India | 2011 |
SastaSundar
|
An online marketplace for healthcare products is operated. | Kolkata, India, India | 2011 |
PharmEasy
|
Provider of an online pharmacy and healthcare platforms | Mumbai, India, India | 2015 |
Sodexo
|
Employee benefits payment cards are provided via an online platform. | - | 1966 |
Happay
|
Expense management software and corporate cards are offered to businesses. | Bengaluru, India, India | 2012 |
Truemeds
|
Provider of an online pharmacy and telehealth platform | Mumbai, India, India | 2019 |
Jeeves
|
Payment and corporate financial cards are provided digitally by Jeeves. | New York, United States, United States | 2019 |
Netmeds
|
Provider of an online store for medicines and healthcare products | Chennai, India, India | 2015 |
Medlife
|
Provider of an online pharmacy for medications | Bengaluru, India, India | 2014 |
Business Activity of Medplus Health Services Limited
Medplus Health Services Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including other hospital and medical care activities, medical and dental practice, nursing, pathology, blood bank services, etc.. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. | Locked |
Business activity turnover details for Medplus Health Services Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Medplus Health Services Limited
Medplus Health Services Limited is audited by B S R and Co (ICAI peer reviewed, certificate valid till 2029-04-30) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| B S R and Co (ICAI peer reviewed, certificate valid till 2029-04-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Medplus Health Services Limited
Medplus Health Services Limited is currently managed by 6 directors, with 27 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
Financials of Medplus Health Services Limited FY 2026 filings available
Medplus Health Services Limited reported revenue of ₹6,892.47 Cr (up 12.33% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue from Operations | ₹6,892.47 Cr | ₹6,136.05 Cr | ₹5,624.86 Cr | ₹4,557.58 Cr | ₹3,779.28 Cr |
| Other Income | ₹71.32 Cr | ₹48.62 Cr | ₹40.01 Cr | ₹46.08 Cr | ₹31.36 Cr |
| Total Income | ₹6,963.79 Cr | ₹6,184.67 Cr | ₹5,664.86 Cr | ₹4,603.65 Cr | ₹3,810.64 Cr |
| Cost of Materials Consumed | ₹88.73 Cr | ₹61.72 Cr | ₹44.53 Cr | ₹25.88 Cr | ₹19.44 Cr |
| Purchases of Stock-in-Trade | ₹5,030.47 Cr | ₹4,572.48 Cr | ₹4,537.85 Cr | ₹3,752.93 Cr | ₹3,122.37 Cr |
| Changes in Inventories | -₹34.59 Cr | ₹6.46 Cr | -₹190.76 Cr | -₹221.12 Cr | -₹159.44 Cr |
| Employee Benefit Expense | ₹884.53 Cr | ₹726.02 Cr | ₹625.52 Cr | ₹545.13 Cr | ₹393.92 Cr |
| Finance Costs | ₹120.49 Cr | ₹102.59 Cr | ₹96.43 Cr | ₹83.03 Cr | ₹66.43 Cr |
| Depreciation & Amortisation | ₹282.87 Cr | ₹249.84 Cr | ₹224.21 Cr | ₹181.56 Cr | ₹119.36 Cr |
| Other Expenses | ₹315.96 Cr | ₹282.27 Cr | ₹253.63 Cr | ₹189.09 Cr | ₹130.62 Cr |
| Total Expenses | ₹6,688.46 Cr | ₹6,001.38 Cr | ₹5,591.42 Cr | ₹4,556.49 Cr | ₹3,692.7 Cr |
| Profit Before Exceptional Items & Tax | ₹275.33 Cr | ₹183.29 Cr | ₹73.44 Cr | ₹47.16 Cr | ₹117.94 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹275.33 Cr | ₹183.29 Cr | ₹73.44 Cr | ₹47.16 Cr | ₹117.94 Cr |
| Total Tax Expense | ₹55.72 Cr | ₹33.06 Cr | ₹7.87 Cr | -₹2.94 Cr | ₹23.23 Cr |
| Net Profit | ₹219.61 Cr | ₹150.23 Cr | ₹65.58 Cr | ₹50.11 Cr | ₹94.72 Cr |
| attributable to Owners | ₹219.64 Cr | ₹150.32 Cr | ₹65.47 Cr | ₹49.76 Cr | ₹95.8 Cr |
| attributable to NCI | -₹4.3 Lakh | -₹8.9 Lakh | ₹10.4 Lakh | ₹34.2 Lakh | -₹1.09 Cr |
| Other Comprehensive Income | ₹2.17 Cr | ₹14.6 Lakh | -₹5.5 Lakh | ₹33.4 Lakh | ₹1.83 Cr |
| Total Comprehensive Income | ₹221.78 Cr | ₹150.38 Cr | ₹65.52 Cr | ₹50.44 Cr | ₹96.54 Cr |
| EBITDA (computed) | ₹678.69 Cr | ₹535.72 Cr | ₹394.09 Cr | ₹311.75 Cr | ₹303.73 Cr |
| Basic EPS | ₹18.33 | ₹12.57 | ₹5.48 | ₹4.17 | ₹8.55 |
| Diluted EPS | ₹18.29 | ₹12.52 | ₹5.45 | ₹4.17 | ₹8.52 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹3,932.53 Cr | ₹3,360.1 Cr | ₹3,004.8 Cr | ₹2,796.72 Cr |
| Non-current Assets | ₹1,863.88 Cr | ₹1,516.58 Cr | ₹1,437.25 Cr | ₹1,316 Cr |
| Current Assets | ₹2,068.65 Cr | ₹1,843.52 Cr | ₹1,567.55 Cr | ₹1,480.72 Cr |
| Property, Plant & Equipment | ₹318.36 Cr | ₹290.67 Cr | ₹318.57 Cr | ₹288.34 Cr |
| Inventories | ₹1,381.69 Cr | ₹1,345.1 Cr | ₹1,340.23 Cr | ₹1,144.09 Cr |
| Trade Receivables | ₹26.96 Cr | ₹13.27 Cr | ₹17.5 Cr | ₹8.65 Cr |
| Cash & Equivalents | ₹198.41 Cr | ₹86.05 Cr | ₹91.21 Cr | ₹228.38 Cr |
| Equity (Net Worth) | ₹1,974.65 Cr | ₹1,739.9 Cr | ₹1,577.36 Cr | ₹1,490.5 Cr |
| Equity Share Capital | ₹24.01 Cr | ₹23.94 Cr | ₹23.91 Cr | ₹23.86 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹0 | ₹0 | ₹0 | ₹0 |
| Current Liabilities | ₹689.29 Cr | ₹576.59 Cr | ₹525.94 Cr | ₹476.58 Cr |
| Total Liabilities | ₹1,957.87 Cr | ₹1,620.2 Cr | ₹1,427.44 Cr | ₹1,306.22 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹495.58 Cr | ₹540.43 Cr | ₹143.74 Cr | ₹90.41 Cr | ₹169.89 Cr |
| Investing Cash Flow | -₹127.72 Cr | -₹317.61 Cr | -₹82.8 Cr | ₹429.44 Cr | -₹703.13 Cr |
| Financing Cash Flow | -₹255.51 Cr | -₹227.98 Cr | -₹198.1 Cr | -₹170.25 Cr | ₹440.43 Cr |
| Capital Expenditure | ₹123.03 Cr | ₹59.45 Cr | ₹84.4 Cr | ₹169.01 Cr | ₹117.72 Cr |
| Free Cash Flow (computed) | ₹372.55 Cr | ₹480.98 Cr | ₹59.34 Cr | -₹78.6 Cr | ₹52.17 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹112.36 Cr | -₹5.16 Cr | -₹137.17 Cr | ₹349.6 Cr | -₹92.81 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q1 FY24 | Q4 FY23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1,864.39 Cr | ₹1,806.12 Cr | ₹1,679.33 Cr | ₹1,542.63 Cr | ₹1,509.61 Cr | ₹1,561.45 Cr | ₹1,576.17 Cr | ₹1,488.83 Cr | ₹1,490.5 Cr | ₹1,441.47 Cr | ₹1,284.3 Cr | ₹1,252.98 Cr |
| Other Income | ₹20.6 Cr | ₹18.24 Cr | ₹17.47 Cr | ₹15.02 Cr | ₹15.79 Cr | ₹12.52 Cr | ₹11.6 Cr | ₹8.71 Cr | ₹10.46 Cr | ₹9.79 Cr | ₹9.39 Cr | ₹13.69 Cr |
| Total Income | ₹1,884.98 Cr | ₹1,824.36 Cr | ₹1,696.8 Cr | ₹1,557.65 Cr | ₹1,525.4 Cr | ₹1,573.96 Cr | ₹1,587.77 Cr | ₹1,497.54 Cr | ₹1,500.96 Cr | ₹1,451.26 Cr | ₹1,293.69 Cr | ₹1,266.68 Cr |
| Cost of Materials Consumed | ₹25.63 Cr | ₹20.52 Cr | ₹23.41 Cr | ₹19.18 Cr | ₹19.55 Cr | ₹14.24 Cr | ₹15.55 Cr | ₹12.38 Cr | ₹12.25 Cr | ₹12.54 Cr | ₹9.91 Cr | ₹8.93 Cr |
| Purchases of Stock-in-Trade | ₹1,395.12 Cr | ₹1,361.5 Cr | ₹1,220.9 Cr | ₹1,052.95 Cr | ₹1,136.72 Cr | ₹1,106.91 Cr | ₹1,083.01 Cr | ₹1,245.84 Cr | ₹1,163.31 Cr | ₹1,152.29 Cr | ₹1,041.94 Cr | ₹1,015.54 Cr |
| Changes in Inventories | -₹49.8 Cr | -₹48.35 Cr | -₹4.05 Cr | ₹67.61 Cr | -₹47.63 Cr | ₹49.43 Cr | ₹103.31 Cr | -₹98.65 Cr | -₹21.66 Cr | -₹42.09 Cr | -₹40.96 Cr | -₹54.49 Cr |
| Employee Benefit Expense | ₹238.12 Cr | ₹232.65 Cr | ₹213.32 Cr | ₹200.44 Cr | ₹194.17 Cr | ₹189.68 Cr | ₹180.34 Cr | ₹161.82 Cr | ₹160.6 Cr | ₹159.53 Cr | ₹147.6 Cr | ₹148.59 Cr |
| Finance Costs | ₹33.48 Cr | ₹30.83 Cr | ₹28.82 Cr | ₹27.37 Cr | ₹26.84 Cr | ₹25.97 Cr | ₹25.12 Cr | ₹24.66 Cr | ₹25.13 Cr | ₹24.5 Cr | ₹23.27 Cr | ₹22.27 Cr |
| Depreciation & Amortisation | ₹75.95 Cr | ₹72.74 Cr | ₹68.56 Cr | ₹65.62 Cr | ₹64.21 Cr | ₹62.47 Cr | ₹63.14 Cr | ₹60.03 Cr | ₹59.22 Cr | ₹57.11 Cr | ₹52.42 Cr | ₹55.8 Cr |
| Other Expenses | ₹86.15 Cr | ₹81.18 Cr | ₹76.91 Cr | ₹71.73 Cr | ₹70.43 Cr | ₹68.66 Cr | ₹69.52 Cr | ₹73.67 Cr | ₹70.13 Cr | ₹67.43 Cr | ₹54.46 Cr | ₹52.78 Cr |
| Total Expenses | ₹1,804.64 Cr | ₹1,751.07 Cr | ₹1,627.86 Cr | ₹1,504.89 Cr | ₹1,464.29 Cr | ₹1,517.36 Cr | ₹1,539.98 Cr | ₹1,479.75 Cr | ₹1,468.97 Cr | ₹1,431.3 Cr | ₹1,288.64 Cr | ₹1,249.42 Cr |
| Profit Before Exceptional Items & Tax | ₹80.34 Cr | ₹73.29 Cr | ₹68.94 Cr | ₹52.77 Cr | ₹61.12 Cr | ₹56.6 Cr | ₹47.78 Cr | ₹17.79 Cr | ₹31.99 Cr | ₹19.96 Cr | ₹5.05 Cr | ₹17.25 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹80.34 Cr | ₹73.29 Cr | ₹68.94 Cr | ₹52.77 Cr | ₹61.12 Cr | ₹56.6 Cr | ₹47.78 Cr | ₹17.79 Cr | ₹31.99 Cr | ₹19.96 Cr | ₹5.05 Cr | ₹17.25 Cr |
| Total Tax Expense | ₹16.37 Cr | ₹15.5 Cr | ₹13.43 Cr | ₹10.42 Cr | ₹9.8 Cr | ₹10.73 Cr | ₹9.09 Cr | ₹3.44 Cr | -₹1.58 Cr | ₹6.26 Cr | ₹1.29 Cr | -₹9.31 Cr |
| Net Profit | ₹63.97 Cr | ₹57.79 Cr | ₹55.5 Cr | ₹42.34 Cr | ₹51.32 Cr | ₹45.87 Cr | ₹38.7 Cr | ₹14.34 Cr | ₹33.56 Cr | ₹13.71 Cr | ₹3.77 Cr | ₹26.56 Cr |
| attributable to Owners | ₹63.98 Cr | ₹57.81 Cr | ₹55.5 Cr | ₹42.36 Cr | ₹51.34 Cr | ₹45.89 Cr | ₹38.74 Cr | ₹14.36 Cr | ₹33.4 Cr | ₹13.73 Cr | ₹3.79 Cr | ₹26.58 Cr |
| attributable to NCI | -₹1 Lakh | -₹1.9 Lakh | ₹10,000 | ₹1.5 Lakh | -₹1.5 Lakh | -₹1.6 Lakh | -₹3.7 Lakh | -₹1.9 Lakh | ₹16.5 Lakh | -₹2.1 Lakh | -₹2.1 Lakh | -₹2.3 Lakh |
| Other Comprehensive Income | ₹2.17 Cr | ₹0 | ₹0 | ₹0 | ₹14.6 Lakh | ₹0 | ₹0 | ₹0 | -₹3.58 Cr | ₹1.25 Cr | ₹0 | -₹3.8 Lakh |
| Total Comprehensive Income | ₹66.14 Cr | ₹57.79 Cr | ₹55.5 Cr | ₹42.34 Cr | ₹51.47 Cr | ₹45.87 Cr | ₹38.7 Cr | ₹14.34 Cr | ₹29.98 Cr | ₹14.96 Cr | ₹3.77 Cr | ₹26.52 Cr |
| EBITDA (computed) | ₹189.77 Cr | ₹176.86 Cr | ₹166.32 Cr | ₹145.75 Cr | ₹152.17 Cr | ₹145.04 Cr | ₹136.04 Cr | ₹102.48 Cr | ₹116.33 Cr | ₹101.57 Cr | ₹80.74 Cr | ₹95.32 Cr |
| Basic EPS | ₹5.33 | ₹4.82 | ₹4.63 | ₹3.54 | ₹4.32 | ₹3.84 | ₹3.24 | ₹1.20 | ₹2.81 | ₹1.15 | ₹0.32 | ₹2.24 |
| Diluted EPS | ₹5.33 | ₹4.81 | ₹4.62 | ₹3.53 | ₹4.30 | ₹3.82 | ₹3.23 | ₹1.20 | ₹2.79 | ₹1.14 | ₹0.32 | ₹2.24 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Retail | ₹1,828.98 Cr | ₹70.52 Cr | ₹3,109.77 Cr | ₹1,856.63 Cr |
| Diagnostic services | ₹34.78 Cr | ₹96.4 Lakh | ₹137.73 Cr | ₹101.1 Cr |
| Others | ₹62.9 Lakh | ₹42.9 Lakh | ₹91.2 Lakh | ₹14.1 Lakh |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Retail | ₹6,760.11 Cr | ₹238.81 Cr | - | - |
| Diagnostic services | ₹130.99 Cr | ₹1.74 Cr | - | - |
| Others | ₹1.37 Cr | ₹67.2 Lakh | - | - |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue from Operations | ₹860.57 Cr | ₹713.1 Cr | ₹467.03 Cr | ₹213.93 Cr | ₹145.71 Cr |
| Other Income | ₹10.77 Cr | ₹8.94 Cr | ₹7.29 Cr | ₹16.24 Cr | ₹9.54 Cr |
| Total Income | ₹871.33 Cr | ₹722.03 Cr | ₹474.32 Cr | ₹230.17 Cr | ₹155.26 Cr |
| Cost of Materials Consumed | ₹81.24 Cr | ₹61.62 Cr | ₹44.52 Cr | ₹25.78 Cr | ₹19.36 Cr |
| Purchases of Stock-in-Trade | ₹570.39 Cr | ₹486.03 Cr | ₹307.4 Cr | ₹131.49 Cr | ₹97.21 Cr |
| Changes in Inventories | ₹71.9 Lakh | -₹1.09 Cr | -₹88.3 Lakh | -₹39.6 Lakh | ₹2 Cr |
| Employee Benefit Expense | ₹54.3 Cr | ₹47.22 Cr | ₹43.61 Cr | ₹28.15 Cr | ₹13.73 Cr |
| Finance Costs | ₹8.31 Cr | ₹8.63 Cr | ₹8.4 Cr | ₹6.55 Cr | ₹2.63 Cr |
| Depreciation & Amortisation | ₹26.39 Cr | ₹26.94 Cr | ₹24.17 Cr | ₹15.31 Cr | ₹4.63 Cr |
| Other Expenses | ₹46.82 Cr | ₹41.53 Cr | ₹40.07 Cr | ₹15.71 Cr | ₹10.11 Cr |
| Total Expenses | ₹788.16 Cr | ₹670.86 Cr | ₹467.28 Cr | ₹222.58 Cr | ₹149.68 Cr |
| Profit Before Exceptional Items & Tax | ₹83.17 Cr | ₹51.17 Cr | ₹7.04 Cr | ₹7.59 Cr | ₹5.58 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹83.17 Cr | ₹51.17 Cr | ₹7.04 Cr | ₹7.59 Cr | ₹5.58 Cr |
| Total Tax Expense | ₹20.76 Cr | ₹10.84 Cr | -₹2.54 Cr | ₹2.04 Cr | ₹0 |
| Net Profit | ₹62.41 Cr | ₹40.34 Cr | ₹9.58 Cr | ₹5.54 Cr | ₹5.58 Cr |
| Other Comprehensive Income | ₹37.5 Lakh | ₹20 Lakh | ₹43.5 Lakh | -₹35.6 Lakh | ₹11.7 Lakh |
| Total Comprehensive Income | ₹62.79 Cr | ₹40.54 Cr | ₹10.02 Cr | ₹5.19 Cr | ₹5.7 Cr |
| EBITDA (computed) | ₹117.87 Cr | ₹86.73 Cr | ₹39.61 Cr | ₹29.44 Cr | ₹12.84 Cr |
| Basic EPS | ₹5.21 | ₹3.37 | ₹0.80 | ₹0.46 | ₹0.50 |
| Diluted EPS | ₹5.20 | ₹3.36 | ₹0.80 | ₹0.46 | ₹0.50 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹1,465 Cr | ₹1,399.45 Cr | ₹1,312.23 Cr | ₹1,271.94 Cr |
| Non-current Assets | ₹1,109.84 Cr | ₹1,124.18 Cr | ₹1,136.3 Cr | ₹1,121.36 Cr |
| Current Assets | ₹355.16 Cr | ₹275.27 Cr | ₹175.93 Cr | ₹150.58 Cr |
| Property, Plant & Equipment | ₹91.1 Cr | ₹100.72 Cr | ₹109.08 Cr | ₹93.56 Cr |
| Inventories | ₹26.77 Cr | ₹18.32 Cr | ₹13.96 Cr | ₹6.69 Cr |
| Trade Receivables | ₹132.61 Cr | ₹121.62 Cr | ₹65.83 Cr | ₹37.61 Cr |
| Cash & Equivalents | ₹46.45 Cr | ₹11.3 Cr | ₹13 Cr | ₹35.7 Cr |
| Equity (Net Worth) | ₹1,316.11 Cr | ₹1,240.35 Cr | ₹1,172.63 Cr | ₹1,141.28 Cr |
| Equity Share Capital | ₹24.01 Cr | ₹23.94 Cr | ₹23.91 Cr | ₹23.86 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹0 | ₹0 | ₹0 | ₹0 |
| Current Liabilities | ₹63.5 Cr | ₹68.8 Cr | ₹55.85 Cr | ₹48.01 Cr |
| Total Liabilities | ₹148.88 Cr | ₹159.1 Cr | ₹139.6 Cr | ₹130.66 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹61.98 Cr | ₹46.68 Cr | ₹7.67 Cr | ₹11.41 Cr | -₹20.71 Cr |
| Investing Cash Flow | -₹22.03 Cr | -₹39.19 Cr | -₹24.43 Cr | ₹31.72 Cr | -₹633.66 Cr |
| Financing Cash Flow | -₹4.79 Cr | -₹9.91 Cr | -₹5.95 Cr | -₹8.36 Cr | ₹568.63 Cr |
| Capital Expenditure | ₹6.06 Cr | ₹9.24 Cr | ₹12.39 Cr | ₹61.74 Cr | ₹40.63 Cr |
| Free Cash Flow (computed) | ₹55.92 Cr | ₹37.45 Cr | -₹4.72 Cr | -₹50.34 Cr | -₹61.33 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹35.15 Cr | -₹2.42 Cr | -₹22.7 Cr | ₹34.77 Cr | -₹85.74 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q1 FY24 | Q4 FY23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹248.04 Cr | ₹223 Cr | ₹205.65 Cr | ₹183.88 Cr | ₹201.75 Cr | ₹176.79 Cr | ₹156.23 Cr | ₹178.33 Cr | ₹148.37 Cr | ₹148.1 Cr | ₹71.89 Cr | ₹86.95 Cr |
| Other Income | ₹2.49 Cr | ₹2.7 Cr | ₹2.94 Cr | ₹2.65 Cr | ₹2.65 Cr | ₹2.19 Cr | ₹2.25 Cr | ₹1.84 Cr | ₹1.9 Cr | ₹1.82 Cr | ₹1.81 Cr | ₹2.54 Cr |
| Total Income | ₹250.52 Cr | ₹225.7 Cr | ₹208.59 Cr | ₹186.53 Cr | ₹204.4 Cr | ₹178.98 Cr | ₹158.48 Cr | ₹180.17 Cr | ₹150.27 Cr | ₹149.92 Cr | ₹73.7 Cr | ₹89.49 Cr |
| Cost of Materials Consumed | ₹18.14 Cr | ₹20.52 Cr | ₹23.41 Cr | ₹19.18 Cr | ₹19.55 Cr | ₹14.24 Cr | ₹15.45 Cr | ₹12.38 Cr | ₹11.97 Cr | ₹12.54 Cr | ₹9.9 Cr | ₹8.91 Cr |
| Purchases of Stock-in-Trade | ₹173.63 Cr | ₹147.83 Cr | ₹131.41 Cr | ₹117.52 Cr | ₹137.2 Cr | ₹121.25 Cr | ₹101.06 Cr | ₹126.52 Cr | ₹101.07 Cr | ₹101.57 Cr | ₹42.22 Cr | ₹54.52 Cr |
| Changes in Inventories | ₹13.5 Lakh | ₹46.1 Lakh | -₹37.5 Lakh | ₹49.8 Lakh | -₹1.09 Cr | -₹14.2 Lakh | -₹7.7 Lakh | ₹21.4 Lakh | -₹62.6 Lakh | ₹1.01 Cr | -₹53.4 Lakh | ₹2.19 Cr |
| Employee Benefit Expense | ₹14.71 Cr | ₹14.06 Cr | ₹13.26 Cr | ₹12.26 Cr | ₹12 Cr | ₹12.14 Cr | ₹11.84 Cr | ₹11.23 Cr | ₹11.68 Cr | ₹11.29 Cr | ₹9.76 Cr | ₹9.85 Cr |
| Finance Costs | ₹1.4 Cr | ₹2.4 Cr | ₹2.37 Cr | ₹2.15 Cr | ₹2.08 Cr | ₹2.35 Cr | ₹2.09 Cr | ₹2.1 Cr | ₹2.11 Cr | ₹2.1 Cr | ₹2.08 Cr | ₹2.05 Cr |
| Depreciation & Amortisation | ₹5.44 Cr | ₹7.19 Cr | ₹7.04 Cr | ₹6.72 Cr | ₹6.51 Cr | ₹6.5 Cr | ₹7.47 Cr | ₹6.47 Cr | ₹6.4 Cr | ₹6.27 Cr | ₹5.54 Cr | ₹5.33 Cr |
| Other Expenses | ₹14.02 Cr | ₹11.41 Cr | ₹10.87 Cr | ₹10.51 Cr | ₹10.24 Cr | ₹10.61 Cr | ₹11.02 Cr | ₹9.64 Cr | ₹11.35 Cr | ₹10.9 Cr | ₹8.22 Cr | ₹5.2 Lakh |
| Total Expenses | ₹227.47 Cr | ₹203.87 Cr | ₹187.97 Cr | ₹168.85 Cr | ₹186.49 Cr | ₹166.95 Cr | ₹148.84 Cr | ₹168.56 Cr | ₹143.94 Cr | ₹145.68 Cr | ₹77.18 Cr | ₹82.9 Cr |
| Profit Before Exceptional Items & Tax | ₹23.06 Cr | ₹21.83 Cr | ₹20.61 Cr | ₹17.68 Cr | ₹17.91 Cr | ₹12.03 Cr | ₹9.64 Cr | ₹11.61 Cr | ₹6.32 Cr | ₹4.24 Cr | -₹3.49 Cr | ₹6.59 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹23.06 Cr | ₹21.83 Cr | ₹20.61 Cr | ₹17.68 Cr | ₹17.91 Cr | ₹12.03 Cr | ₹9.64 Cr | ₹11.61 Cr | ₹6.32 Cr | ₹4.24 Cr | -₹3.49 Cr | ₹6.59 Cr |
| Total Tax Expense | ₹6.38 Cr | ₹5.25 Cr | ₹4.98 Cr | ₹4.15 Cr | ₹3.93 Cr | ₹2.66 Cr | ₹1.89 Cr | ₹2.35 Cr | -₹3.59 Cr | ₹1.05 Cr | ₹0 | ₹88.1 Lakh |
| Net Profit | ₹16.67 Cr | ₹16.58 Cr | ₹15.63 Cr | ₹13.53 Cr | ₹13.98 Cr | ₹9.37 Cr | ₹7.75 Cr | ₹9.26 Cr | ₹9.92 Cr | ₹3.19 Cr | -₹3.49 Cr | ₹5.71 Cr |
| Other Comprehensive Income | ₹37.5 Lakh | ₹0 | ₹0 | ₹0 | ₹20 Lakh | ₹0 | ₹0 | ₹0 | -₹51.5 Lakh | ₹36.6 Lakh | ₹0 | -₹36.8 Lakh |
| Total Comprehensive Income | ₹17.05 Cr | ₹16.58 Cr | ₹15.63 Cr | ₹13.53 Cr | ₹14.18 Cr | ₹9.37 Cr | ₹7.75 Cr | ₹9.26 Cr | ₹9.4 Cr | ₹3.55 Cr | -₹3.49 Cr | ₹5.34 Cr |
| EBITDA (computed) | ₹29.89 Cr | ₹31.41 Cr | ₹30.02 Cr | ₹26.55 Cr | ₹26.5 Cr | ₹20.88 Cr | ₹19.2 Cr | ₹20.18 Cr | ₹14.83 Cr | ₹12.61 Cr | ₹4.13 Cr | ₹13.96 Cr |
| Basic EPS | ₹1.39 | ₹1.38 | ₹1.31 | ₹1.13 | ₹1.17 | ₹0.78 | ₹0.65 | ₹0.77 | ₹0.83 | ₹0.27 | ₹-0.29 | ₹0.15 |
| Diluted EPS | ₹1.39 | ₹1.38 | ₹1.30 | ₹1.13 | ₹1.17 | ₹0.78 | ₹0.65 | ₹0.77 | ₹0.83 | ₹0.27 | ₹-0.29 | ₹0.15 |
Shareholding Pattern of Medplus Health Services Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 40.22%, foreign institutional investors hold 15.53%, domestic institutional investors hold 27.82%, retail and other public shareholders hold 16.40% of Medplus Health Services Limited. The company had 77,278 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 40.22% | 40.29% | 40.29% | 40.32% | 40.34% | 40.39% |
| Public | 59.74% | 59.66% | 59.66% | 59.63% | 59.62% | 59.57% |
| Employee Trusts | 0.04% | 0.04% | 0.05% | 0.05% | 0.05% | 0.05% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | |
|---|---|---|---|---|---|
| Promoters | 40.22% | 40.34% | 40.39% | 40.43% | 40.43% |
| Public | 59.74% | 59.62% | 59.51% | 59.38% | 59.22% |
| Employee Trusts | 0.04% | 0.05% | 0.10% | 0.19% | 0.35% |
| Promoter change (YoY, %pts) | -0.12 | -0.05 | -0.04 | +0.00 | - |
Board & Governance of Medplus Health Services Limited
As per the corporate governance filing with NSE for the quarter ended 31-DEC-2025, the board of Medplus Health Services Limited has 6 directors - 4 independent and 2 executive. The board is chaired by Gangadi Madhukar Reddy.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Gangadi Madhukar Reddy | Executive Director · CEO-MD · Chairperson | 2006-11-30 | 1 |
| Madhavan Ganesan | Non-Executive - Independent Director | 2021-06-11 | 3 |
| Murali Sivaraman | Non-Executive - Independent Director | 2021-06-11 | 5 |
| Aparna Surabhi | Non-Executive - Independent Director | 2024-07-01 | 3 |
| Cherukupalli Bhaskar Reddy | Executive Director | 2023-10-26 | 1 |
| Muralidharan Thyagarajan | Non-Executive - Independent Director | 2024-12-18 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Murali Sivaraman (Chairperson), Aparna Surabhi, Madhavan Ganesan |
| Nomination and remuneration committee | Muralidharan Thyagarajan (Chairperson), Murali Sivaraman, Madhavan Ganesan, Aparna Surabhi |
| Stakeholders Relationship Committee | Madhavan Ganesan (Chairperson), Gangadi Madhukar Reddy, Cherukupalli Bhaskar Reddy |
| Risk Management Committee | Madhavan Ganesan (Chairperson), Aparna Surabhi, Murali Sivaraman, Gangadi Madhukar Reddy, Cherukupalli Bhaskar Reddy, Muralidharan Thyagarajan |
| Corporate Social Responsibility Committee | Aparna Surabhi (Chairperson), Madhavan Ganesan, Gangadi Madhukar Reddy, Cherukupalli Bhaskar Reddy |
Group Structure of Medplus Health Services Limited
Medplus Health Services Limited has 12 subsidiary companies. This group structure data is as of FY 2024. The corporate group structure reflects Medplus Health Services Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Nova Sud Pharmaceuticals Private Limited | U24232TG2007PTC055895 | - |
| Sai Sridhar Pharma Private Limited | U24232TG2007PTC055902 | - |
| Mhs Pharmaceuticals Private Limited | U24233TG2008PTC059624 | - |
| Wynclark Pharmaceuticals Private Limited | U24239TG2007PTC052676 | - |
| Deccan Medisales Private Limited | U51397KA2011PTC059204 | - |
| Venkata Krishna Enterprises Private Limited | U51909TG2010PTC071012 | - |
Showing major subsidiaries. Total: 12.
Charges & Borrowings of Medplus Health Services Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Dec 2021 | Axis Bank Limited | ₹11 Cr | Open |
| 04 Dec 2017 | State Bank of India | ₹8.3 Cr | Satisfied |
| 04 Mar 2015 | State Bank of India | ₹20 Cr | Satisfied |
| 05 Sep 2013 | State Bank of India | ₹105 Cr | Satisfied |
| 30 Jun 2012 | State Bank of India | ₹40 Cr | Satisfied |
Total charge records: 7 View all charges
Employees and EPFO Compliance at Medplus Health Services Limited
Medplus Health Services Limited has a workforce of 1,343 employees as of Apr 10, 2025.
Employee and EPFO history for Medplus Health Services Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Medplus Health Services Limited
GST registrations and filing compliance for Medplus Health Services Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Medplus Health Services Limited
Credit ratings, litigation, and regulatory alerts for Medplus Health Services Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medplus Health Services Limited
MSME payment history for Medplus Health Services Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medplus Health Services Limited
Corporate group structure for Medplus Health Services Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medplus Health Services Limited
MCA filings and documents for Medplus Health Services Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Medplus Health Services Limited
Recent News on Medplus Health Services Limited
Frequently Asked Questions about Medplus Health Services Limited
Medplus Health Services Limited is an active public limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 30 November 2006 (20+ years old) and is registered under CIN L85110TG2006PLC051845. Listed on BSE: 543427. The company has 1,343 employees.
Medplus Health Services Limited reported revenue of ₹6,892.47 Cr for FY 2026 (up 12.33% YoY) based on consolidated NSE filings.
The current directors of Medplus Health Services Limited are:
- Madhukar Reddy Gangadi - Managing Director
- Muralidharan Thyagarajan - Director
- Aparna Surabhi - Director
- Bhaskar Reddy Cherukupalli - Whole-Time Director
- Mohanakrishna Reddy Arvabumi - Additional Director
- Ajit Pandurang Rangnekar - Additional Director
The primary industry of Medplus Health Services Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.
Yes. Medplus Health Services Limited is listed on BSE with code 543427.
Medplus Health Services Limited can be reached at the registered office: H. No: 11 – 6 – 56 Survey No: 257 & 2581 Opp: Idpl Railway Siding Road Moosapet, Kukatpally, Hyderabad, Telangana, India – 500037, or through the website medplusindia.com.